Click
here to close Hello! We notice that
you are using Internet Explorer, which is not supported by Echinobase
and may cause the site to display incorrectly. We suggest using a
current version of Chrome,
FireFox,
or Safari.
J Bras Nefrol
2020 Mar 01; doi: 10.1590/2175-8239-JBN-2019-0051.
Show Gene links
Show Anatomy links
Irisin and troponin I expression in dialysis patients submitted to remote ischemic preconditioning: a pilot study.
Gehrke FS
,
Gouveia MC
,
Barbosa CGM
,
Murad N
,
Reis BDCAA
,
Fonseca FLA
,
Pereira EC
,
Bacci MR
.
Abstract
BACKGROUND: Renal replacement therapy continues to be related to high hospitalization rates and poor quality of life. All-cause morbidity and mortality in renal replacement therapy in greater than 20% per year, being 44 times greater when diabetes is present, and over 10 times that of the general population. Regardless of treatment, the 5-year survival is 40%, surpassing many types of cancers. Irisin is a hormone that converts white adipose tissue into beige adipose tissue, aggregating positive effects like fat mass control, glucose tolerance, insulin resistance, prevention of muscle loss, and reduction in systemic inflammation.
OBJECTIVES: To determine the serum levels of troponin I in hemodialysis patients submitted to remote ischemic preconditioning (RIPC) associated with irisin expression.
METHODS: This was a prospective, randomized, double-blind clinical trial with patients with chronic kidney disease submitted to hemodialysis for a 6-month period. Troponin I, IL-6, urea, TNF-α, and creatinine levels were determined from blood samples. The expressions of irisin, thioredoxin, Nf-kb, GPX4, selenoprotein and GADPH were also evaluated by RT-PCR.
RESULTS: Samples from 14 hypertensive patients were analyzed, 9 (64.3%) of whom were type 2 diabetics, aged 44-64 years, and 50% of each sex. The difference between pre- and post-intervention levels of troponin I was not significant. No differences were verified between the RIPC and control groups, except for IL-6, although a significant correlation was observed between irisin and troponin I.
CONCLUSION: Remote ischemic preconditioning did not modify irisin or troponin I expression, independent of the time of collection.
Bacci,
Remote ischemic preconditioning in myocardial protection in hemodialysis patients.
2018, Pubmed,
Echinobase
Bacci,
Remote ischemic preconditioning in myocardial protection in hemodialysis patients.
2018,
Pubmed
,
Echinobase
Boström,
A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis.
2012,
Pubmed
Brown,
Comparative mortality from cardiovascular disease in patients with chronic renal failure.
1994,
Pubmed
Burton,
Hemodialysis-induced cardiac injury: determinants and associated outcomes.
2009,
Pubmed
Chen,
Irisin, an exercise-induced myokine as a metabolic regulator: an updated narrative review.
2016,
Pubmed
Cheung,
Cardiac diseases in maintenance hemodialysis patients: results of the HEMO Study.
2004,
Pubmed
Collins,
US Renal Data System 2013 Annual Data Report.
2014,
Pubmed
Eknoyan,
Effect of dialysis dose and membrane flux in maintenance hemodialysis.
2002,
Pubmed
Grossmann,
Profile of the Immune and Inflammatory Response in Individuals With Prediabetes and Type 2 Diabetes.
2015,
Pubmed
Hasegawa,
Prognostic value of highly sensitive troponin T on cardiac events in patients with chronic kidney disease not on dialysis.
2013,
Pubmed
Hausenloy,
Effect of remote ischaemic preconditioning on myocardial injury in patients undergoing coronary artery bypass graft surgery: a randomised controlled trial.
2007,
Pubmed
Hoole,
Cardiac Remote Ischemic Preconditioning in Coronary Stenting (CRISP Stent) Study: a prospective, randomized control trial.
2009,
Pubmed
Huh,
FNDC5 and irisin in humans: I. Predictors of circulating concentrations in serum and plasma and II. mRNA expression and circulating concentrations in response to weight loss and exercise.
2012,
Pubmed
Johnsen,
The remote ischemic preconditioning algorithm: effect of number of cycles, cycle duration and effector organ mass on efficacy of protection.
2016,
Pubmed
Kersten,
Acute hyperglycemia abolishes ischemic preconditioning in vivo.
1998,
Pubmed
Kersten,
Diabetes abolishes ischemic preconditioning: role of glucose, insulin, and osmolality.
2000,
Pubmed
Kharbanda,
Translation of remote ischaemic preconditioning into clinical practice.
2009,
Pubmed
McIntyre,
Hemodialysis-induced cardiac dysfunction is associated with an acute reduction in global and segmental myocardial blood flow.
2008,
Pubmed
McIntyre,
Effects of hemodialysis on cardiac function.
2009,
Pubmed
Miki,
Effects of diabetes on myocardial infarct size and cardioprotection by preconditioning and postconditioning.
2012,
Pubmed
Moreno-Navarrete,
Irisin is expressed and produced by human muscle and adipose tissue in association with obesity and insulin resistance.
2013,
Pubmed
Moretti,
The EUROpean and Chinese cardiac and renal Remote Ischemic Preconditioning Study (EURO-CRIPS CardioGroup I): A randomized controlled trial.
2018,
Pubmed
Nygaard,
Irisin in blood increases transiently after single sessions of intense endurance exercise and heavy strength training.
2015,
Pubmed
Otsuka,
Association between high-sensitivity cardiac troponin T levels and the predicted cardiovascular risk in middle-aged men without overt cardiovascular disease.
2010,
Pubmed
Park,
Remote ischemic preconditioning in hemodialysis: a pilot study.
2014,
Pubmed
Park,
Relationship between extracellular water fraction of total body water estimated by bioimpedance spectroscopy and cardiac troponin T in chronic haemodialysis patients.
2009,
Pubmed
Pickup,
Is type II diabetes mellitus a disease of the innate immune system?
1998,
Pubmed
Ragosta,
Coronary flow reserve abnormalities in patients with diabetes mellitus who have end-stage renal disease and normal epicardial coronary arteries.
2004,
Pubmed
Robinson,
Worldwide, mortality risk is high soon after initiation of hemodialysis.
2014,
Pubmed
Saran,
US Renal Data System 2017 Annual Data Report: Epidemiology of Kidney Disease in the United States.
2018,
Pubmed
Tosaki,
The evolution of diabetic response to ischemia/reperfusion and preconditioning in isolated working rat hearts.
1996,
Pubmed
Tsang,
Preconditioning the diabetic heart: the importance of Akt phosphorylation.
2005,
Pubmed
Tsuchiya,
Resistance exercise induces a greater irisin response than endurance exercise.
2015,
Pubmed
Wang,
Inflammatory markers and risk of type 2 diabetes: a systematic review and meta-analysis.
2013,
Pubmed
Whittington,
The diabetic heart: too sweet for its own good?
2012,
Pubmed
Wider,
Remote ischemic preconditioning fails to reduce infarct size in the Zucker fatty rat model of type-2 diabetes: role of defective humoral communication.
2018,
Pubmed
de Jager,
Cardiovascular and noncardiovascular mortality among patients starting dialysis.
2009,
Pubmed
del Valle,
Absence of ischemic preconditioning protection in diabetic sheep hearts: role of sarcolemmal KATP channel dysfunction.
2003,
Pubmed
